PRESSEMITTEILUNGEN

Toronto (ots/PRNewswire) – Die “Colorectal Cancer Association of Canada” (CCAC, kanadische Vereinigung für Kolorektalkrebs) lädt aufstrebende Werbedesigner und Filmemacher ein, ihre Talente einzusetzen, um durch ihre Teilnahme an dem zweiten Jahreswettbewerb “International Public Service Announcement (PSA) Contest” (Ausschreibungswettbewerb für öffentliche Institutionen) weltweit das Bewusstsein für Kolorektalkrebs zu fördern. Neben Bargeldpreisen von bis zu $4.500,- CAD [...]

Continue reading

Association Of Canada, Bowel Cancer, Cancer Association, Cancer Canada, Ccac, Colorectal, Colorectal Cancer, Film Board Of Canada, Inspiration, Kampagne, MäNner Und Frauen, National Film Board, National Film Board Of Canada, Ogilvy Montreal, Ots, Prnewswire, Psa, Psas, Public Service Announcement, Quot

– Strong feasibility study data for improved product concept with 91% sensitivity and 87% specificity – FDA sets February date for Pre-IDE meeting ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– New Products/Molecular diagnostics Subtitle: – Strong feasibility study data for improved product concept [...]

Continue reading

Adhoc, Berlin Germany, Blood Test, Colorectal, Colorectal Cancer, Company Today Announced That, Corporate News, Design Changes, Diagnostic Company, Epigenomics Ag, Feasibility Phase, Feasibility Study, Generation Product, Market Surveys, Molecular Diagnostics, Prime Standard, Seattle Wa Usa, Second Generation, Specificity, Today Announced That

Current CFO Oliver Schacht leaving by March 31, 2011; Experienced CFO Successor to join April 1st, 2011 ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Personnel/Molecular diagnostics Subtitle: Current CFO Oliver Schacht leaving by March 31, 2011; Experienced CFO Successor to join April 1st, [...]

Continue reading

Adhoc, April 1st, Berlin Germany, Blood Test, Colorectal, Colorectal Cancer, Commercialization, Company Employment, Confidentiality Obligations, Corporate News, Eans, Epigenomics Ag, Fda Approval, Molecular Diagnosis, Molecular Diagnostics, Prime Standard, Professor Dr, Seattle Wa Usa, Supervisory Board, Test Professor

Third distribution agreement for Epi proColon completes the picture for the Middle East ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Molecular diagnostics Subtitle: Third distribution agreement for Epi proColon completes the picture for the Middle East BERLIN and SEATTLE, November 5, 2010 [...]

Continue reading

Adhoc, Blood Plasma, Cancer Diagnostics, Colorectal, Colorectal Cancer, Diagnostic Test, Distant Organs, Distribution Agreement, Distribution Deal, Distributor Agreement, Dpc, East Berlin, Ecx, Epigenomics Ag, Molecular Diagnostics, Prime Standard, Qatar Kuwait, Screening Programs, Survival Chances, United Arab Emirates

Second distributor to be signed-up for Epi proColon – more expected to come shortly ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Molecular diagnostics Subtitle: Second distributor to be signed-up for Epi proColon – more expected to come shortly BERLIN and SEATTLE, October [...]

Continue reading

Adhoc, Blood Plasma, Cancer Diagnostics, Cancer Screening, Colonoscopy, Colorectal, Colorectal Cancer, Company Today Announced That, Diagnostic Test, Distant Organs, Distributor Agreement, Ecx, Epigenomics Ag, Molecular Diagnostics, Prime Standard, Screening Centers, Screening Guidelines, Survival Chances, Today Announced That, Turkish Ministry

Independent validation of laboratory test used in PRESEPT Study shows that the test finds 86% of the cancers ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Molecular diagnostics Subtitle: Independent validation of laboratory test used in PRESEPT Study shows that the test finds [...]

Continue reading

Barcelona Spain, Benchmark Study, Biomarker, Cancer Cases, Cancer Detection, Cancer Diagnostics, Colonoscopy, Colorectal, Colorectal Cancer Screening, Company Announced That, Discoverer, Epigenomics, European Gastroenterology, Independent Validation, Laboratory Test, Medical Affairs, Molecular Diagnostics, Poster Presentation, Prospective Evaluation, Senior Vice President

——————————————————————————– Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. ——————————————————————————– Unternehmen/Molekulardiagnostik Berlin und Seattle, 18. Oktober 2010 (euro adhoc) – ARUP Laboratories, Salt Lake City, UT, USA, ein Lizenzmehmer von Epigenomics, wird auf der heute beginnenden ASCO-NCI-EORTC Jahreskonferenz 2010 über Molekulare Marker für Krebs in Hollywood, FL, USA, klinische Daten [...]

Continue reading

Abstract Id, Adhoc, Arup Laboratories, Asco, Colorectal, Colorectal Cancer Patients, Corporate News, Diplomat Hotel Hollywood, Diplomat Hotel Hollywood Fl, Eortc, Epigenomics, Fl Usa, Methylated, Molecular Markers, Nci, Oncology, Salt Lake City, Technology Development, Westin Diplomat Hotel, Westin Diplomat Hotel Hollywood Fl

Epigenomics expands commercial reach for CE-marked product beyond home market ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Molecular diagnostics Subtitle: Epigenomics expands commercial reach for CE-marked product beyond home market Berlin, Germany, and Tel Aviv, Israel, October 14, 2010 (euro adhoc) – [...]

Continue reading

Adhoc, Berlin Germany, Biomarker, Chief Executive Officer, Colorectal, Colorectal Cancer, Commercialization, Corporate News, Diagnostic Test, Distribution Deal, Distributor Agreement, Ecx, Epigenomics Ag, Good Chance, Israel Cancer Association, Molecular Diagnostics, Prevalent Cancers, Prime Standard, Routine Blood Tests, Tel Aviv Israel

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/Molecular diagnostics Berlin, Germany and Surrey, United Kingdom, 6th October, 2010 (euro adhoc) – The cancer molecular diagnostics company Epigenomics AG and NextPharma Technologies, the leading European provider of product development, contract manufacturing and cold [...]

Continue reading

Adhoc, Berlin Germany, Biotechnology Industries, Cold Chain, Colorectal, Colorectal Cancer, Compliant Version, Contract Manufacturing, Development Contract, Diagnostic Test, European Provider, Food And Drug Administration, Food And Drug Administration Fda, Iso 13485, Molecular Diagnostics, Nextpharma, San Diego California, Senior Vice President, Test Kit, Us Food And Drug Administration

Montreal (ots/PRNewswire) – Um die Mitteilung auf Social Media Release abzurufen, klicken Sie bitte auf: http://smr.newswire.ca/en/ccac/colorectal-cancer-association-launches -contest Der Darmkrebs-Verband Kanadas (CCAC – Colorectal Cancer Association of Canada) ist freut sich die Eröffnung des zweiten Ausschreibungswettbewerb des öffentlichen Dienstes am 1. September 2010 bekannt geben zu dürfen. ZIEL DES WETTBEWERBS: Der Wettbewerb dient der öffentlichen Bewusstseinssteigerung [...]

Continue reading

Association Of Canada, Cancer Association, Cancer Canada, Ccac, Colorectal, Colorectal Cancer, Darmkrebs, Erkrankung, Fitness, Frauen üBer 50, Krankheit, Krebs, Montreal, Newswire, Ots, Schr, Senken, Welt

Key Figures * Revenue: EUR 1.0 million in H1 2010 (H1 2009: EUR 2.1 million) * EBIT: EUR -5.4 million in H1 2010 (H1 2009: EUR -4.8 million) * Net loss: EUR 5.4 million in H1 2010 (H1 2009: EUR 4.8 million) * Liquid assets: EUR 32.3 million as of 30/06/2010 (31/12/2009: EUR 6.1 million) [...]

Continue reading

Adhoc, Arup, Colorectal, Colorectal Cancer, Corporate News, Eans, Epigenomics Ag, Eur 2, Eur 4, Financial Position, H1, Leading Conference, Liquid Assets, Lung Cancer, Medical Laboratories, Molecular Diagnostics, Presept, Reflex, Specificity, Warnex

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– New Products/Molecular diagnostics/Partnerships Press release Berlin and Seattle, July 21, 2010 (euro adhoc) – Epigenomics AG (Frankfurt Prime Standard: ECX) announced that its licensee ARUP Laboratories, Salt Lake City, UT, U.S.A., has launched a laboratory-developed test [...]

Continue reading

Adhoc, Arup Laboratories, Biomarker, Biomarkers, Chief Executive Officer, Clinical Validation, Colorectal, Colorectal Cancer, Dna Methylation, Eans, Ecx, Epigenomics Ag, Europe Asia, Molecular Diagnostics, Prime Standard, Quest Diagnostics, Salt Lake City, Stage Disease, Test Performance, Warnex

——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– New Products/Molecular diagnostics 20.07.2010 Berlin and Seattle, July 20, 2010 – Epigenomics AG (ISIN: DE000A0BVT96) reports that its licensee ARUP Laboratories, Salt [...]

Continue reading

Arup Laboratories, Biomarker, Colonoscopy, Colorectal, Colorectal Cancer, Commercial Laboratories, Dna Methylation, Epigenomics Ag, German Securities Trading Act, Government Facilities, Molecular Diagnostics, National Reference Laboratory, Routine Screening Tests, Salt Lake City, Screening Methods, Securities Trading Act, Stage Disease, Teaching Hospitals, U S A Today, University Teaching

Innovative Septin9 blood-test offers new opportunities in colorectal cancer early detection Efficient partnerships between laboratories and Epigenomics in educating physicians and patients Survey shows high level of awareness and acceptance of Septin9 testing among primary care physicians ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. [...]

Continue reading

Adhoc, Berlin Brandenburg, Berlin Germany, Blood Test, Colorectal, Colorectal Cancer, Corporate News, Diagnostic Laboratories, Epigenomics, Heinz, High Priority, Laboratory Network, Level Of Awareness, Mecklenburg Vorpommern, Molecular Diagnostics, New Opportunities, Primary Care Physicians, Regional Focus, Seattle Wa Usa, Subtitle